Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis

NCT03091426 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Omiganan
DRUG: Omiganan
DRUG: Omiganan
DRUG: Placebo

Sponsor

Maruho Co., Ltd.